Market revenue in 2023 | USD 2,401.4 million |
Market revenue in 2030 | USD 5,642.7 million |
Growth rate | 13% (CAGR from 2023 to 2030) |
Largest segment | Neurostimulation and neuromodulation devices |
Fastest growing segment | Biomaterials |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biomaterials, Neurostimulation and Neuromodulation Devices |
Key market players worldwide | Axogen Inc, Stryker Corp, St. Jude Medical, Baxter International Inc, Boston Scientific Corp, Integra Lifesciences Holdings Corp, Medtronic PLC, Polyganics, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nerve repair and regeneration market will help companies and investors design strategic landscapes.
Neurostimulation and neuromodulation devices was the largest segment with a revenue share of 67.24% in 2023. Horizon Databook has segmented the Asia Pacific nerve repair and regeneration market based on biomaterials, neurostimulation and neuromodulation devices covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific nerve repair and regeneration market is anticipated to exhibit lucrative growth during the forecast period. Rising prevalence of psychiatric disorders coupled with unmet need for effective & long term treatment solutions is expected to present significant growth opportunities for nerve repair and regeneration in this region.
Moreover, high R&D investments by global market players owing to their lowcost structure are among the key drivers of the market in Asia Pacific region. Rising awareness about neurological disease treatment options and improvements in clinical development framework of emerging economies are expected to drive the market growth.
Furthermore, establishment of organizations such as the Asia Pacific Centre for Neuromodulation (APCN), which is founded for conducting research and promoting awareness about associated benefits of deep brain stimulation, is anticipated to boost market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific nerve repair and regeneration market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific nerve repair and regeneration market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account